Upload
alina
View
176
Download
0
Tags:
Embed Size (px)
DESCRIPTION
GROUP C Salazar, Riccel Salcedo , Von Saldana, Emmanuel Sales, Maria Stephanie Salonga , Cryscel September 21, 2009. CHOLEDOCHOLITHIASIS. Pathophysiology. - PowerPoint PPT Presentation
Citation preview
CHOLEDOCHOLITHIASISGROUP CSalazar, RiccelSalcedo, VonSaldana, EmmanuelSales, Maria StephanieSalonga, Cryscel
September 21, 2009
Pathophysiology
Choledocholithiasis occurs as a result of either the primary formation of stones in the common bile duct (CBD) or the passage of gallstones from the gallbladder through the cystic duct into the CBD.
http://www.nlm.nih.gov/medlineplus/ency/article/000274.htm
Pathophysiology
Majority of the bile duct stones are cholesterol stones formed in the gallbladder which then migrates into the exrahepatic biliary tree through the cystic duct [secondary ]
Obstruction of the CBD by gallstones leads to symptoms and complications that include pain, jaundice, cholangitis, pancreatits and sepsis.
Harrison’s Principles of Internal Medicine 17th ed p.1999
Causes of Primary calculi in CBD 1. Hepatobiliary parasitism or
chronic, recurrent cholangitis 2. Congenital anomalies of the bile
ducts 3. Dilated or sclerosed or strictured
ducts 4. MD3 gene defect leading to
impaired biliary phospholipids secretion
Harrison’s Principles of Internal Medicine 17th ed p.1999
Causes of Secondary stones 1. Cholesterol stones 2. Black pigment stones 3. Brown pigment stones
Secondary stones are those who were formed in the gallbladder and later on migrate into the CBD
Risk Factors for developing choledocholelithiasis
Age
• 25% of elderly patients may have calculi in the CBD
Previous History of Gallstones
• Undetected duct stones are left behind in ~1-5% of cholecystectomy patients
Infection with parasites
• Ascaris Lumbricoides
• Clonorchis sinensis
http://www.nlm.nih.gov/medlineplus/ency/article/000274.htm
Clinical Manifestations Can be completely asymptomatic Symptoms usually do not occur
unless the stone blocks the common bile duct
Symptoms and signs usually present as RUQ abdominal pain Jaundice Fever Tea colored urine Acholic stools Nausea and or Vomiting
Abdominal PainPresentation
• Pain in RUQ or MUQ
• Sharp, cramping or dull
• Pain radiating to the back or below the scapula
• Pain worsening after eating fatty/greasy food
Patient• In our Patient:• - Denies of
having abdominal pain
• [But choledocholelithiasis can present as a painless jaundice]
Jaundice Presentation
• Painless jaundice may occur in patients with cholelithiasis
• -caused by increased bilirubin in the blood
• - post hepatic/obstructive jaundice
• Initially presents as Icteric sclera
Patient• Positive for
jaundice
Tea-colored urine and Acholic Stools
Presentation• signifies post hepatic cause of jaundice [Obstructive Jaundice]
Patient• Positive for Tea/Dark Colored urine
• Patient denies acholic stools
COMPLICATIONS
Cholangitis
May be acute or chronic Symptoms result from inflammation
Caused by partial obstruction to the flow of bile
Presence of bacteria in the bile culture in 75% of patients with acute cholangitis early in the symptomatic course
Cholangitis
CHARCOT’S TRIAD Characteristic presentation of acute cholangitis Biliary pain, jaundice and spiking fever
with chills Blood cultures are frequently positive, and
leukocytosis is typicalNonsuppurative acute cholangitis
Most common and may respond relatively rapidly to supportive measures and to treatment with antibiotics
Cholangitis
Suppurative acute cholangitis Presence of pus under pressure in a
completely obstructed ductal system leads to symptoms of toxicity▪ REYNOLDS PENTAD▪ Mental confusion and septic shock▪ Biliary pain, jaundice and spiking fever with
chills Response to antibiotics is poor Multiple hepatic abscesses are present Mortality rate approaches 100% ▪ Endoscopic or surgical relief of the
obstruction and drainage of the infected bile
Cholangitis
Endoscopic management Effective as surgical intervention
ERCP with endoscopic sphincterotomy Preferred initial procedure for both
establishing a definitive diagnosis and providing effective therapy
Safe
Obstructive Jaundice
Gradual obstruction of the CBD jaundice or pruritus without associated symptoms of biliary colic or cholangitis
Painless jaundice Associated chronic calculous
cholecystitis is very common Absence of a palpable gallbladder
Biliary obstruction causes progressive dilatation of the intrahepatic bile ducts
Hepatic bile flow is suppressed
Reabsorption and regurgitation of conjugated bilirubin into the bloodstream
Jaundice, dark urine (bilirubinuria), light-colored (acholic) stools
Obstructive Jaundice CBD stones should be suspected in any
patient with cholecystitis whose serum bilirubin level is >85.5 mol/L (5 mg/dL)
Maximum bilirubin level is seldom >256.5 mol/L (15.0 mg/dL) in patients with choledocholithiasis
Serum alkaline phosphatase level is almost always elevated
May be a two- to tenfold elevation of serum aminotransferases, especially in association with acute obstruction
Pancreatitis
Most common associated entity discovered in patients with nonalcoholic acute pancreatitis is biliary tract disease
Complicates: acute cholecystitis: 15% Choledocholithiasis: >30%
Common factor appears to be the passage of gallstones through the common duct
Pancreatitis
Coexisting pancreatitis should be suspected in patients with symptoms of cholecystitis who develop: back pain or pain to the left of the abdominal
midline prolonged vomiting with paralytic ileus a pleural effusion, especially on the left side
Surgical treatment of gallstone disease is usually associated with resolution of the pancreatitis
Secondary Biliary Cirrhosis May complicate prolonged or intermittent
duct obstruction with or without recurrent cholangitis
May be progressive even after correction of the obstructing process
Increasingly severe hepatic cirrhosis may lead to portal hypertension or to hepatic failure and death
May also be associated with clinically relevant deficiencies of the fat-soluble vitamins A, D, E, and K
DIAGNOSIS
DIAGNOSIS Laboratory studies Imaging studies
Ultrasonography MRC Endoscopic cholangiography
Laboratory Studies
Not specific for the diagnosis of choledocholithiasis
Increase in serum bilirubin, alkaline phosphatase, gamma-glutamyl transpeptidase
Moderate elevations on aminotranferases
Ultrasonography
•Commonly the first test•Useful for documenting stones in the gallbladder and determining the size of the common bile duct (90% accuracy). Shows a dilated common bile duct (>8 mm in diameter) in a patient with gallstones, jaundice, and biliary pain - highly suggestive of common bile duct stones. •Detection of CBD stones is impeded by the presence of gas in the duodenum, possible reflection and refraction of the sound beam by curvature of the duct, and the location of the duct beyond the optimal focal point of the transducer
Very accurate in the detection of biliary tree obstruction and ductal dilatation, both intrahepatic and extrahepatic.
Has a sensitivity of 75-90% in the detection of CBD stones, which makes it an essential tool in the evaluation of patients with jaundice.
Capable of defining the level of the obstruction and provides information about the surrounding structures, especially the pancreas.
MAGNETIC RESONANCE CHOLANGIOGRAPHY
Provides excellent anatomic detail and has a sensitivity and specificity of 95 and 89%, respectively, at detecting choledocholithiasis
Cost, inconvenience, and limitations (eg, obesity, presence of metal objects, eg, pacemakers) are some of its disadvantages.
Ultrasonography
Endoscopic cholangiography Gold standard for diagnosing common bile
duct stones Has a distinct advantage of providing a
therapeutic option at the time of diagnosis The CBD is cannulated through the
ampulla, contrast material is injected, and films are obtained. The experience of the endoscopist is the best predictor of success, which is 90-95% in expert hands.
Endoscopic Cholangiogra
phy
ERC from the same patient shows multiple stones in the common bile duct. Only the top one showed on ultrasound, as the other stones lie in the distal common bile duct behind the duodenum.
TREATMENT
Treatment Medical
ERCP Percutaneous extraction Extracorporeal shock wave lithotripsy
Surgical Open choledochotomy Transcystic exploration Drainage procedures ▪ Transduodenal sphincteroplasty ▪ Choledochoduodenostomy▪ Choledochojejunostomy
Cholecystectomy
Treatment Patients with symptomatic gallstones and suspected
common bile duct stones, either preoperative endoscopic cholangiography or an intraoperative cholangiogram will document the bile duct stones.
If an endoscopic cholangiogram reveals stones, sphincterotomy and ductal clearance of the stones is appropriate, followed by a laparoscopic cholecystectomy.
An intraoperative cholangiogram at the time of cholecystectomy will also document the presence or absence of bile duct stones
Laparoscopic common bile duct exploration via the cystic duct or with formal choledochotomy allows the stones to be retrieved in the same setting.
Treatment An open common bile duct exploration is an option
if the endoscopic method has already been tried or is for some reason not feasible.
If a choledochotomy is performed, a T tube is left in place. Stones impacted in the ampulla may be difficult for both endoscopic ductal clearance as well as common bile duct exploration (open or laparoscopic). In these cases the common bile duct is usually
quite dilated (about 2 cm in diameter). Choledochoduodenostomy Roux-en-Y choledochojejunostomy
References
Harrison’s Principles of Internal Medicine, 17th ed.
http://www.nlm.nih.gov/medlineplus/ency/article/000274.htm